CSL: Half Yearly Report and Accounts
Filed with ASX · · 62 pages · English
CSL Limited (ASX:CSL) today announced a net profit after tax (NPAT) of US$646 million for the six months ended 31 December 2013, up US$21 million or 3% on a reported basis when compared to the prior comparable period (PCP). The result included a oneoff U.S. antitrust class action litigation settlement of US$64 million, or US$39 million after tax. KEY ITEMS • Revenue US$2,691 million, up 5% on PCP
Story so far
Earlier from CSL
- Appendix 4E, FY Results and Analysts Presentation
- Changes relating to buy-back - Appendix 3D
- IDELVION(R) (rFIX-FP) - FDA approval
- IDELVION(R) (rFIX-FP) - CHMP recommendation
- Half Year Accounts
Later from CSL
- CSL Settles US Class Action and Updated Profit Guidance
- Full Year Results, Appendix 4E and Analysts Presentation
- New US$500 million Private Placement
- Appointment of Paul Perreault as Executive Director
- Announcement of buy-back
Follow CSL into a list and get an email when it puts out news.
Follow CSL